| Gynial AG - Vroni Gynial, überzogene Tablette | | 66314 | | 01 | | Vroni Gynial | | überzogene Tablette | | G03HB01 | | Cyproteron und Estrogen | | 13.10.2016 | | |
| | Composition | | ethinylestradiolum 0.035 mg, cyproteroni acetas 2 mg, lactosum monohydricum 47.165 mg, maydis amylum, maltodextrinum, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 0.272 mg, macrogolum 4000, natrii citras dihydricus, macrogolum 400, E 104, aluminii hydroxidum, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), pro compresso obducto corresp. natrium 7.1 µg. | | Packungsbestandteile | | | | | | Principe actif | Concentr. |
|---|
| Cyproterone Acétate | 2 mg | | Ethinyl Estradiol | 0.035 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 0.272 mg | | | Macrogol | 400 | | | | | | | Maltodextrine | | | | | | | | Natrii Citras Dihydricus | | | | | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 21 | DDP | DDP | B | | Non | | 002 | 3 x 21 | DDP | DDP | B | | Non |
|
|
